证券记录 · 已归档季度
CTKB
Cytek Biosciences, Inc. · Healthcare · Medical - Devices
19被追踪持有人
+4Δ持有人
43.35M持有股份
$150.42M报告持仓市值
+4新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +26.7% ·
股份流向 +8.0% ·
净新建仓位 +20.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | 0 | 60.52M | $268.04M | +6 | −6 |
| Q1 2026 | 76 | +1 | 60.92M | $266.22M | +4 | −3 |
| Q4 2025 | 75 | -1 | 61.04M | $308.28M | — | −1 |
| Q3 2025 | 19 | +4 | 43.35M | $150.42M | +4 | — |
| Q2 2025 | 12 | 0 | 36.22M | $123.14M | +1 | −1 |
| Q1 2025 | 9 | 0 | 9.63M | $38.61M | +1 | −1 |
| Q4 2024 | 9 | +1 | 10.70M | $69.47M | +1 | — |
| Q3 2024 | 7 | 0 | 5.47M | $30.29M | — | — |
| Q2 2024 | 7 | — | 6.05M | $33.76M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ ×8 |
| 2 | The Vanguard Group ✦ (被动) | 6.93M | -10.7% | $24.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 3 | State Street Global Advisors ✦ (被动) | 4.08M | -2.1% | $14.17M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 3.42M | +269.6% | $11.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.78M | +2.0% | $9.66M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 2.54M | 新增 | $8.82M | 0.0% | New | 1 | SEC ↗ ×4 |
| 7 | Goldman Sachs Group ✦ | 1.74M | — | $6.03M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 9 | AQR Capital Management ✦ | 1.02M | -17.6% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 10 | Renaissance Technologies ✦ | 795.54K | -25.2% | $2.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | Arrowstreet Capital ✦ | 361.29K | +150.5% | $1.25M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 187.62K | 新增 | $651,033 | 0.0% | New | 1 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 180.79K | -12.1% | $627,327 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 175.76K | 新增 | $609,884 | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 134.29K | -48.6% | $465,975 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 17 | D. E. Shaw & Co. ✦ | 121.02K | 新增 | $419,946 | 0.0% | New | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 82.30K | -86.7% | $285,595 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 62.13K | +9.3% | $216,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Wellington Management | $8.82M | 0.0% |
| Point72 Asset Management | $651,033 | 0.0% |
| Two Sigma Investments | $609,884 | 0.0% |
| D. E. Shaw & Co. | $419,946 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 164 持有人, 84.77M 股份, $364.62M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 06
SC 13G/A — MILLENNIUM MANAGEMENT LLC
Aug 04
SC 13G — Boston Partners
Jul 08
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据